Treatment experience of hepatic metastases from neuroendocrine tumors using transarterial chemoembolization
https://doi.org/10.25789/YMJ.2020.69.27
Abstract
The efficacy of treatment of neuroendocrine tumor metastases in the liver by transarterial chemoembolism (TACE) was assessed. In a small number of patients it was shown that TACE contributes to normalization of the general condition of patients, reduction of the intensity of carcinoid syndrome manifestations, reduction of metastatic foci, causing a positive response (partial response or stabilization) in more than half of patients.
About the Authors
V. S. Trifanov
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
TRIFANOV Vladimir S. − Cand.Med. Sc., Senior Researcher at Department of Abdominal Onkology No. 1, surgeon oncologist
E. N. Kolesnikov
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
KOLESNIKOV Evgeniy N. − Cand.Med.Sc., Head of Department of Abdominal Onkology No. 1
A. V. Snezhko
Rostov State Medical University
Russian Federation
Russian Federation
SNEZHKO Aleksandr V. − D.Med.Sc., Assistant at Department of Oncology
M. N. Chernyak
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
CHERNYAK Maksim N., endovascular diagnostic and treatment doctor
A. L. Bazaev
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
BAZAEV Adlan L. − postgraduate student
M. Yu. Meshcheryakova
Rostov State Medical University
Russian Federation
Russian Federation
MESHERYAKOVA Milana Yu. – student
References
1. Screening for the neuroendocrine component in stomach cancer / N.S. Karnaukhov, E.A. Novikova, V.S. Trifanov [et al.] //Modern problems of science and education. – 2016. – №25 (5). – P. 45-49.
2. Kit O.I. Neuroendocrine, clinical and morphological aspects of stomach cancer / O.I. Kit. -Novocherkassk: Publ. “Lik”, 2014. - 187 р.
3. Eadens M.J. Curable metastatic colorectal cancer / M.J. Eadens, A. Grothey //Curr. Oncol. Rep. -2011. – №13. P.168-176.
4. Frankel T.L. Hepatic resection for colorectal metastases / T.L. Frankel, M.I. D’Angelica // J Surg. Oncol. – 2014. – №109. – P. 2–7.
5. Galizia M.S. Evaluation of hepatocellular carcinoma size using two-dimensional and volumetric analysis: effect on liver transplantation eligibility /M.S. Galizia, H.G. Töre, H. Chalian // Acad. Radiol. – 2011. – №18. – P. 1555-60.
6. Hepatocellular carcinoma: current management and perspectives for the future / N. Rahbari, A. Mehrabi, N. Mollberg [et al.]. //Ann. Surg. – 2011. – №253. – P. 453–469.
7. Monsky W.L. Treatment planning and volumetric response assessment for Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy / W.L. Monsky, A.S. Garza, I. Kim // Cardiovasc. Intervent. Radiol. – 2011. – №34. – P. 306-18.
8. O'Dorisio T.M., Anthony L.B. A 25-year experience of gastroenteropancreatic neuroendocrine tumors and somatostatin (congeners) analogs: from symptom control to antineoplastic therapy. Front. Horm. Res. – 2015. - №44. – P. 177-92.
9. Trifanov V.S. Clinical, pathological, and immunohistochemical features of pancreatic neuroendocrine tumors / V.S. Trifanov, I.A. Novikova, S.S. Todorov //Journal of clinical oncology. – 2014. – №15. – P. 151-59.
Review
For citations:
Trifanov V.S., Kolesnikov E.N., Snezhko A.V., Chernyak M.N., Bazaev A.L., Meshcheryakova M.Yu. Treatment experience of hepatic metastases from neuroendocrine tumors using transarterial chemoembolization. Yakut Medical Journal. 2020;(1):109-111. https://doi.org/10.25789/YMJ.2020.69.27
Views:
2
Email this article 